API Sourcing in China

JZMed Inc, February 2010, Pages: 210

For years China has been one of the main places for global drug companies to source APIs and pharma intermediates or contract out the manufacturing work of such compounds. However, the fast growth of this Chinese industry experienced significant growth slowdown in the last one year or so. The financial crisis was only one of the factors to blame. It was, in fact, the severe quality incident in supply chain in which Chinese companies were involved that led to the change of raw material sourcing pattern of global pharma companies in China.

On the other hand, under the severe pressure of the current financial crisis, achieving as much cost reduction as possible has never become so critical to all pharma and biotech companies as well as generic drug makers around the world. These factors, coupled with the still low cost labor and cheap raw materials in China, determine that China still presents considerable attractions to many of these companies in the foreseeable future.

To help these companies more effectively source APIs in China, the report “API Sourcing in China” extracted, from the proprietary database of JZMed, top 150 best API suppliers in China including their API products (more than 1,400 in total).

All included API suppliers have their own company profile and are listed in alphabetic order. For each API supplier, in addition to the detailed contact information, a series of technical areas are examines including key business scope, technical capability, manufacturing facility, production scale and capacity, cGMP approval status, quality control management, products to offer, service experience and customers they have served, structure of their scientific team, years in the API supply business, etc.

Besides, all API products are classified into two groups: the one containing all APIs that have been registered with the Western regulatory authorities; the other containing those that have not been registered in the Western countries. The report also sorted out all API suppliers according to their therapeutic focus.

The report is a must-read book to all drug companies and individual professionals that are interested in sourcing APIs in China.

Executive Summary

Part I. Brief Introduction of Chinese API Industry

1.1 Current state of quality control and cGMP standard in China
1.2 Internationally recognized API quality standards followed by Chinese API makers
1.3 Classification of Chinese API suppliers based on their manufacturing capability and quality control management
1.4 Chinese API suppliers classified according to their therapeutic focus

Part II. List of All Chinese-made API Products

2.1 APIs registered with and approved by Western regulatory authorities and their suppliers
2.2 All other APIs and their suppliers

Part III. Company Profile of Top 150 Best Chinese API Suppliers

About JZMed, Inc.

List of Figures

Figure 1. Classification and rating of Chinese API suppliers

List of Tables

Table 1. Current top tier Chinese API suppliers
Table 2. Current second tier Chinese API suppliers
Table 3. List of Chinese companies that have APIs registered with FDA or EMEA/EDQM
Table 4. List of Chinese API suppliers focusing on anticancer medicines (including their API products)
Table 5. List of Chinese API suppliers focusing on cardiovascular medicines (including their API products)
Table 6. List of Chinese API suppliers focusing on anti-diabetes drugs (including their API products)
Table 7. List of Chinese API suppliers focusing on medicines for CNS diseases (including their API products)
Table 8. List of Chinese API suppliers focusing on antibiotic medicines (including their API products)
Table 9. List of Chinese API suppliers focusing on antiviral drugs (including their API products)
Table 10. List of Chinese API suppliers focusing on anti-inflammation medicines (including their API products)
Table 11. List of Chinese companies providing steroid APIs for hormone-related therapies (including their API products)
Table 12. List of Chinese API suppliers focusing on gastro-intestinal medicines (including their API products)
Table 13. List of Chinese API suppliers focusing on anti-fungal medicines (including their API products)
Table 14. List of Chinese API suppliers focusing on anti-histamine medicines (including their API products)
Table 15. List of Chinese API suppliers focusing on anti-malarial medicines (including their API products)
Table 16. List of Chinese API suppliers focusing on anti-osteoporosis medicines (including their API products)
Table 17. List of Chinese API suppliers focusing on ED medicines (including their API products)
Table 18. List of vitamin API suppliers in China (including their API products)
Table 19. List of Chinese companies providing APIs for peptide- or protein-based drugs (including their API products)
Table 20. List of Chinese-made APIs that have been registered with and approved by the Western regulatory authorities (total: 238 API products)
Table 21. List of all other Chinese-made APIs (total: 1173 API products)

Customers who bought this item also bought

• China Wellness Industry Outlook 2016 - Potential Opportunities in Tier-2 and Tier-3 Cities in China
• Market of Paclitaxel Injection in China
• China Drug Distribution Industry Report, 2012-2015
• China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010
• China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010
• China Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• 2013 China Medical Device Regulatory Updates
• China Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Chinese Above-the-neck PPE Markets
• China Blood Products Industry Report, 2011-2012